The objective of this study was to evaluate the impact of a multidisciplinary team (MDT) approach in the management of diabetic foot ulcers (DFUs).
Approach:
A multidisciplinary diabetic foot care center (MDDFCC) was opened at our institution in August 2018. Outcomes of DFU treatment, including re-admission, amputation, and mortality rates, were compared before and after opening the MDDFCC.
Results:
Patients seen after the MDDFCC was opened had a lower risk of 1-year re-admission (hazard ratio [HR] = 0.697, 95% confidence interval [CI]: 0.387–0.988), 1-year major amputation (HR = 0.447, 95% CI: 0.091–0.984), and 1-year disease-specific mortality (HR = 0.277, 95% CI: 0.105–0.730). PEDIS score (HR = 2.343, 95% CI: 1.264–2.971), history of dialysis (HR = 1.858, 95% CI: 1.258–4.053), and consultation with a physiatrist (HR = 0.368, 95% CI: 0.172–0.788), orthopedist (HR = 0.105, 95% CI: 0.042–0.261), or social worker (HR = 0.370, 95% CI: 0.082–0.871) were associated with 1-year major amputation. One-year major amputation (HR = 2.636, 95% CI: 1.586–4.570), age (HR = 1.094, 95% CI: 1.051–1.140), and C-reactive protein level (HR = 1.052, 95% CI: 1.008–1.098) were associated with 1-year disease-specific mortality.
Innovation:
Plastic surgeons received patients at the MDDFCC, with active participation by all contributing members. This arrangement brought advantages, including more aggressive and timely surgical intervention, a more timely and higher rate of percutaneous transluminal angioplasty, and equally robust integrated medical care by all other members.
Conclusion:
The MDDFCC approach may be a potential organizational structure with for treating DFUs, resulting in significant improvements in outcomes of DFU including a lower re-admission, amputation, and mortality.
Get full access to this article
View all access options for this article.
References
1.
IngelfingerJR, JarchoJA. Increase in the incidence of diabetes and its implications. N Engl J Med, 2017; 376(15):1473–1474; doi: 10.1056/NEJMe1616575
SchaperNC, Van NettenJJ, ApelqvistJ, et al.; International Working Group on the Diabetic Foot. Prevention and management of foot problems in diabetes: A summary guidance for daily practice 2015, based on the IWGDF guidance documents. Diabetes Metab Res Rev, 2016; 32(Suppl 1):7–15; doi: 10.1002/dmrr.2695
4.
FrykbergRG, BanksJ. Challenges in the treatment of chronic wounds. Adv Wound Care (New Rochelle), 2015; 4(9):560–582; doi: 10.1089/wound.2015.0635
5.
BrennanMB, HessTM, BartleB, et al.Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes. J Diabetes Complications, 2017; 31(3):556–561; doi: 10.1016/j.jdiacomp.2016.11.020
6.
ArmstrongDG, BoultonAJM, BusSA. Diabetic foot ulcers and their recurrence. N Engl J Med, 2017; 376(24):2367–2375; doi: 10.1056/NEJMra1615439
7.
RaghavA, KhanZA, LabalaRK, et al.Financial burden of diabetic foot ulcers to world: A progressive topic to discuss always. Ther Adv Endocrinol Metab, 2018; 9(1):29–31; doi: 10.1177/2042018817744513
8.
RiceJB, DesaiU, CummingsAK, et al.Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care, 2014; 37(3):651–658; doi: 10.2337/dc13-2176
9.
ChenHY, KuoS, SuPF, et al.Health care costs associated with macrovascular, microvascular, and metabolic complications of type 2 diabetes across time: Estimates from a population-based cohort of more than 0.8 million individuals with up to 15 years of follow-up. Diabetes Care, 2020; 43(8):1732–1740; doi: 10.2337/dc20-0072
10.
HingoraniA, LaMuragliaGM, HenkeP, et al.The management of diabetic foot: A clinical practice guideline by the society for vascular surgery in collaboration with the American podiatric medical association and the society for vascular medicine. J Vasc Surg, 2016; 63(2 Suppl):3S–21S; doi: 10.1016/j.jvs.2015.10.003
11.
WalshJW, HoffstadOJ, SullivanMO, et al.Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med, 2016; 33(11):1493–1498; doi: 10.1111/dme.13054
12.
BoultonAJ, VileikyteL, Ragnarson-TennvallG, et al.The global burden of diabetic foot disease. Lancet, 2005; 366(9498):1719–1724; doi: 10.1016/S0140-6736(05)67698-2
13.
Meza-TorresB, CarinciF, HeissC, et al.Health service organisation impact on lower extremity amputations in people with type 2 diabetes with foot ulcers: Systematic review and meta-analysis. Acta Diabetol, 2021; 58(6):735–747; doi: 10.1007/s00592-020-01662-x
14.
MusuuzaJ, SutherlandBL, KurterS, et al.A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. J Vasc Surg, 2020; 71(4):1433–1446 e3; doi: 10.1016/j.jvs.2019.08.244
15.
AlbrightRH, ManoharNB, MurilloJF, et al.Effectiveness of multidisciplinary care teams in reducing major amputation rate in adults with diabetes: A systematic review & meta-analysis. Diabetes Res Clin Pract, 2020; 161:107996; doi: 10.1016/j.diabres.2019.107996
16.
BuggyA, MooreZ. The impact of the multidisciplinary team in the management of individuals with diabetic foot ulcers: A systematic review. J Wound Care, 2017; 26(6):324–339; doi: 10.12968/jowc.2017.26.6.324
17.
QuinlivanE, JonesSL, CausbyR, et al.Reduction of amputation rates in multidisciplinary foot clinics: A systematic review. Wound Practice Res, 2014; 22(3):155–162.
18.
SumpioBE, ArmstrongDG, LaveryLA, et al.; SVS/APMA writing group. The role of interdisciplinary team approach in the management of the diabetic foot: A joint statement from the Society for vascular surgery and the American podiatric medical association. J Vasc Surg, 2010; 51(6):1504–1506; doi: 10.1016/j.jvs.2010.04.010
19.
van AckerK, LegerP, HartemannA, et al.Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: A systematic literature review. Diabetes Metab Res Rev, 2014; 30(8):635–645; doi: 10.1002/dmrr.2523
20.
FrykbergRG, ZgonisT, ArmstrongDG, et al.; American College of Foot and Ankle Surgeons. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg, 2006; 45(5 Suppl):S1–S66; doi: 10.1016/S1067-2516(07)60001-5
21.
Van AckerK, WeylerJ, De LeeuwI. The diabetic foot project of Flanders, the northern part of Belgium: Implementation of the St Vincent consensus. Sensibilisation and registration in diabetes centres. Acta Clin Belg, 2001; 56(1):21–31; doi: 10.1179/acb.2001.005
22.
LipskyBA, SennevilleE, AbbasZG, et al.; International Working Group on the Diabetic Foot (IWGDF). Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev, 2020; 36(Suppl 1):e3280; doi: 10.1002/dmrr.3280
23.
UzzamanMM, JukakuS, KambalA, et al.Assessing the long-term outcomes of minor lower limb amputations: A 5-year study. Angiology, 2011; 62(5):365–371; doi: 10.1177/0003319710395558
24.
ThewjitcharoenY, SripatpongJ, KrittiyawongS, et al.Changing the patterns of hospitalized diabetic foot ulcer (DFU) over a 5-year period in a multi-disciplinary setting in Thailand. BMC Endocr Disord, 2020; 20(1):89; doi: 10.1186/s12902-020-00568-7
25.
MatricaliGA, DereymaekerG, MulsE, et al.Economic aspects of diabetic foot care in a multidisciplinary setting: A review. Diabetes Metab Res Rev, 2007; 23(5):339–347; doi: 10.1002/dmrr.706
26.
PrompersL, HuijbertsM, SchaperN, et al.Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale study. Diabetologia, 2008; 51(10):1826–1834; doi: 10.1007/s00125-008-1089-6
27.
RinkelWD, LuitenJ, van DongenJ, et al.In-hospital costs of diabetic foot disease treated by a multidisciplinary foot team. Diabetes Res Clin Pract, 2017; 132:68–78; doi: 10.1016/j.diabres.2017.07.029
28.
HorswellRL, BirkeJA, PatoutCA.Jr., A staged management diabetes foot program versus standard care: A 1-year cost and utilization comparison in a state public hospital system. Arch Phys Med Rehabil, 2003; 84(12):1743–1746; doi: 10.1016/s0003-9993(03)00477-5
29.
JoretMO, OsmanK, DeanA, et al.Multidisciplinary clinics reduce treatment costs and improve patient outcomes in diabetic foot disease. J Vasc Surg, 2019; 70(3):806–814; doi: 10.1016/j.jvs.2018.11.032
30.
OrtegonMM, RedekopWK, NiessenLW. Cost-effectiveness of prevention and treatment of the diabetic foot: A Markov analysis. Diabetes Care, 2004; 27(4):901–907; doi: 10.2337/diacare.27.4.901
31.
DorresteijnJA, KriegsmanDM, AssendelftWJ, et al.Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev, 2012; 10:CD001488; doi: 10.1002/14651858.CD001488.pub4
32.
DorresteijnJA, KriegsmanDM, AssendelftWJ, et al.Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev, 2014; 2014(12):CD001488; doi: 10.1002/14651858.CD001488.pub5
33.
HoogeveenRC, DorresteijnJA, KriegsmanDM, et al.Complex interventions for preventing diabetic foot ulceration. Cochrane Database Syst Rev, 2015; 2015(8):CD007610; doi: 10.1002/14651858.CD007610.pub3
34.
van NettenJJ, PricePE, LaveryLA, et al.; International Working Group on the Diabetic Foot. Prevention of foot ulcers in the at-risk patient with diabetes: A systematic review. Diabetes Metab Res Rev, 2016; 32(Suppl 1):84–98; doi: 10.1002/dmrr.2701
35.
ChuanF, TangK, JiangP, et al.Reliability and validity of the Perfusion, Extent, Depth, Infection and Sensation (PEDIS) classification system and score in patients with diabetic foot ulcer. PLoS One, 2015; 10(4):e0124739; doi: 10.1371/journal.pone.0124739
36.
HolscherCM, HicksCW, CannerJK, et al.Unplanned 30-day readmission in patients with diabetic foot wounds treated in a multidisciplinary setting. J Vasc Surg, 2018; 67(3):876–886; doi: 10.1016/j.jvs.2017.07.131
37.
RubioJA, JiménezS, Lázaro-MartínezJL. Mortality in patients with diabetic foot ulcers: Causes, risk factors, and their association with evolution and severity of ulcer. J Clin Med, 2020; 9(9); doi: 10.3390/jcm9093009
38.
VanGH, AmouyalC, BourronO, et al.Diabetic foot ulcer management in a multidisciplinary foot centre: One-year healing, amputation and mortality rate. J Wound Care, 2021; 30(Sup6):S34–S41; doi: 10.12968/jowc.2021.30.Sup6.S34
